Furthermore, The Kaplan–Meier curves indicated that patients with high TLS signature and CD103+ CD8+ Trm cells signature in breast cancer conferred significantly best prognosis than those with low TLS signature and CD103+ CD8+ Trm cells signature (Figure 4B). This evidence concerns the gene CD8A and breast carcinoma.